Detalles de la búsqueda
1.
Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan.
J Clin Psychopharmacol;
43(4): 365-368, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37216369
2.
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.
BMC Psychiatry;
23(1): 473, 2023 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380997
3.
Effects of electroconvulsive therapy on the use of anxiolytics and sleep medications: a propensity score-matched analysis.
Psychiatry Clin Neurosci;
77(1): 30-37, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36215112
4.
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
Psychiatry Clin Neurosci;
77(10): 559-568, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37684711
5.
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.
Int J Neuropsychopharmacol;
25(10): 818-826, 2022 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35723038
6.
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
Ann Gen Psychiatry;
21(1): 52, 2022 Dec 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36567327
7.
Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophrenia.
CNS Spectr;
: 1-6, 2020 Sep 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32883397
8.
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Psychiatry Clin Neurosci;
73(10): 642-648, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31437336
9.
Second-Generation Antipsychotic Monotherapy Contributes to the Discontinuation of Anticholinergic Drugs in Hospitalized Patients With Schizophrenia.
J Clin Psychopharmacol;
42(6): 591-593, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36193896
10.
Blood Biomarkers Predict the Cognitive Effects of Aripiprazole in Patients with Acute Schizophrenia.
Int J Mol Sci;
18(3)2017 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28272307
11.
Serum levels of brain-derived neurotrophic factor (BDNF), proBDNF and plasma 3-methoxy-4-hydroxyphenylglycol levels in chronic schizophrenia.
Ann Gen Psychiatry;
15: 1, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26770258
12.
Marked Improvement of Meige Syndrome in a Japanese Male Patient with Schizophrenia After Switching from Risperidone to Paliperidone: A Case Report.
J UOEH;
38(3): 233-6, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27627971
13.
Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
Psychiatry Clin Neurosci;
74(12): 667-669, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32881226
14.
Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients.
Ann Gen Psychiatry;
13: 19, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25089150
15.
Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Hum Psychopharmacol;
28(5): 466-70, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23813968
16.
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.
Neuropsychopharmacol Rep;
43(1): 33-39, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394160
17.
Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).
CNS Spectr;
17(3): 155-63, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22883353
18.
Aripiprazole altered plasma levels of brain-derived neurotrophic factor and catecholamine metabolites in first-episode untreated Japanese schizophrenia patients.
Hum Psychopharmacol;
27(1): 33-8, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22213405
19.
The case of a depressed man who exhibited hyperprolactinemia and galactopoiesis after electroconvulsive therapy.
J ECT;
28(1): 56, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21778911
20.
Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depression.
World J Biol Psychiatry;
23(10): 785-793, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35193470